Biotech Microcap Rockets After Securing Major Capital Infusion at Premium Valuation [Globe and Mail, The (Toronto, Canada)]
Serina Therapeutics, Inc. (SER)
Company Research
Source: Globe and Mail, The
In an environment where capital efficiency and clear regulatory pathways are critical, investors are closely watching which companies can extend their runway while positioning themselves for meaningful clinical milestones. Shares of Serina Therapeutics, Inc. ( NYSE American: SER ) are surging Wednesday after the company announced a private placement financing that could bring in up to $30 million in total proceeds, providing capital to advance its registrational study for advanced Parkinson's disease. The financing includes an initial $15 million tranche expected to close on March 20, 2026, with a second tranche of up to an additional $15 million anticipated by April 30, 2026. Notably, the securities were priced at $2.25 per share, representing a significant premium to the company's recent trading price, signaling investor confidence in the company's clinical and regulatory trajectory. The structure also includes 50% warrant coverage with an exercise price of $5.00 per share. If
Show less
Read more
Impact Snapshot
Event Time:
SER
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SER alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SER alerts
High impacting Serina Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
SER
News
- Serina Therapeutics Secures up to $30 Million in Private Placement to Advance Registrational Trial of SER-252 for Advanced Parkinson's Disease [Yahoo! Finance]Yahoo! Finance
- Serina Therapeutics Secures up to $30 Million in Private Placement to Advance Registrational Trial of SER-252 for Advanced Parkinson’s DiseaseGlobeNewswire
- Serina Therapeutics Announces Dosing of First Patient in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson’s DiseaseGlobeNewswire
- Serina Therapeutics Announces First Patient Enrolled in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson's DiseaseGlobeNewswire
- Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event [Yahoo! Finance]Yahoo! Finance
SER
Sec Filings
- 3/20/26 - Form 4
- 2/17/26 - Form 4
- 2/17/26 - Form 4
- SER's page on the SEC website